Clinical trials
Anemia, Sickle Cell trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 7 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 5 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
| Terminated | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brugmann University Hospital | 4 |
| Novartis Pharmaceuticals | 4 |
| Agios Pharmaceuticals, Inc. | 3 |
| Hanane EL KENZ | 3 |
| AstraZeneca | 2 |
| Queen Fabiola Children's University Hospital | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| CSL Behring | 1 |
| Centre Hospitalier Universitaire Saint Pierre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 32 |
| Vaso-Occlusive Crises | 7 |
| Thalassemia | 4 |
| Hematologic Diseases | 3 |
| Hemoglobinopathies | 3 |
| Anemia | 2 |
| Anemia, Diamond-Blackfan | 2 |
| Genetic Diseases, Inborn | 2 |
| Sickle Cell Trait | 2 |
| alpha-Thalassemia | 2 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.